Multiple Endocrine Neoplasia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Conditions: Multiple Endocrine Neoplasia; Recurrent Thyroid Gland Carcinoma; Thyroid Gland Medullary CarcinomaInterventions: Drug: Sorafenib Tosylate; Other: Pharmacological Study; Other: Laboratory Biomarker AnalysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2006 Category: Research Source Type: clinical trials
Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Conditions: Multiple Endocrine Neoplasia; Recurrent Thyroid Cancer; Thyroid Gland Medullary CarcinomaInterventions: Drug: sorafenib tosylate; Other: pharmacological study; Other: laboratory biomarker analysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2006 Category: Research Source Type: clinical trials
Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Conditions: Multiple Endocrine Neoplasia; Recurrent Thyroid Gland Carcinoma; Thyroid Gland Medullary CarcinomaInterventions: Drug: Sorafenib Tosylate; Other: Pharmacological Study; Other: Laboratory Biomarker AnalysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2006 Category: Research Source Type: clinical trials
Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Conditions: Multiple Endocrine Neoplasia; Recurrent Thyroid Cancer; Thyroid Gland Medullary CarcinomaInterventions: Drug: sorafenib tosylate; Other: pharmacological study; Other: laboratory biomarker analysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2006 Category: Research Source Type: clinical trials